Implementation of physician order entry system continues
Hospital officials call bond rating "disappointing", but say financial picture is improving
PAMF places temporary freeze on new primary care patients
Gregory retires, duties split between COS, associate dean
Health insurance options announced for employees at Stanford, Packard hospitals
The
accomplishments of your colleagues
and associates are making a significant impact.
Detailed news releases and/or source material
are available at the
Stanford University Medical Center
Office of News and Public Affairs,
701 Welch Road, Suite 2207, Palo Alto, CA 94304;
phone (650) 725-5376 or 723-6911;
and on the World Wide Web
(http://www-med.stanford.edu/MedCenter/Communications/)
CANCER RISK - Family history is an important risk factor for most, if not all, cancers and malignancies that occur early in life, according to an analysis of data involving 45,000 pairs of twins. The study Ð published in the July issue of Cancer Epidemiology, Biomarkers and Prevention Ð was authored by Neil Risch, professor of genetics and, by courtesy, of statistics and of health research and policy.
MEMORY - A study of the relationship between the enzyme CaMKII and NMDA receptors has provided researchers with useful insight into memory formation. The research on the enzyme critical to memory and learning was published in the June 14 issue of Nature by postdoctoral fellow K. Ulrich Bayer and Howard Schulman, professor of neurobiology.
NICOTINE affects blood-vessel formation and might be used to revive tissue deprived of blood by a stroke or heart attack if administered cautiously to avoid tumor growth, according to a study in the July issue of Nature Medicine. The study was authored by John P. Cooke, professor of cardiovascular medicine, and Chris Heeschen, postdoctoral fellow in cardiovascular medicine. The researchers believe nicotine works by binding to a receptor on the surface of endothelial cells that recognizes acetylcholine.
MITOSIS - Julie Reimann Ð an MD/PhD student working in the lab of Peter Jackson, assistant professor of pathology Ð and colleagues reported in the June 1 issue of Cell that they have found the protein Emi1, or early mitotic inhibitor 1, the molecular beat counter that may coordinate chromosome segregation with mitosis. Clinically, the researchers are interested in determining if Emi1 plays a role in cancer development.
